Netherlands· NL-aa7b7337fe6b

Tofacitinib Accord 10 mg filmomhulde tabletten

A tofacitinib product containing tofacitinibcitraat, registered in Netherlands by Accord Healthcare B.V.. The same ATC class is registered in 13 of our 19 countries.

ATC L04AF01

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about tofacitinibcitraatAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Tofacitinib is registered in 13 of 19 countries.

Countries holding a registration under ATC L04AF01 (tofacitinib), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
7 of them publish a price we can compare per daily dose

Search tofacitinib products by name

Tofacitinib · ATC L04AF01

13 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Icelandprice
Ireland
Japan
Netherlands
Norwayprice
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of tofacitinib costs, country by country.

Normalised to the WHO defined daily dose (10 mg), the median price runs from $1.99 in United States to $17.31 in Switzerland — a ×8.7 gap.

2 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Tofacitinib · price per daily dose (10 mg)

USD · FX 28 Sept 2026

CH Switzerland$17.31
US United States$1.99 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: TOFACITINIBCITRAAT
Manufacturer: Accord Healthcare B.V.
Country: Netherlands (NL)
ATC code: L04AF01
ATC class: Tofacitinib
Defined daily dose: 10 mg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
135037

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

512 interactions on record for tofacitinib.

Graded by severity as the source publishes them — 333 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check tofacitinib against other medicines How interaction checks work

Tofacitinib · interactions on record

512 records

333 severe
171 moderate
8 minor

Most severe, free to view

PrednisoloneA07EA01severe
HydrocortisoneA07EA02severe
PrednisoneA07EA03severe
BetamethasoneA07EA04severe

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Tofacitinib in 14 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All tofacitinib products

Authorised across Europe · EMA

The same active substance is authorised in 14 EEA countries. Names it is sold under:

Austria · Tofacitinib Devatis, Tofacitinib Stada
Bulgaria · Tофацитиниб Devatis
Denmark · Tofacitinib Accord, Tofacitinib Newbury
Spain · Tofacitinib Stada
Finland · Tofacitinib Devatis, Tofacitinib Stada
France · Tofacitinib Stada
United Kingdom (Northern Ireland) · Tofacitinib Amarox, Tofacitinib Brown & Burk Uk
Croatia · Tofacitinib Accord, Tofacitinib Stada
Iceland · Xeljanz
Liechtenstein · Xeljanz
Malta · Tofacitinib Stada
Norway · Tofacitinib Accord, Tofacitinib Devatis
Portugal · Tofacitinib Bluepharma
Sweden · Tofacitinib Devatis, Tofacitinib Newbury

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c3f91f92-c93c-42c5-9a5f-f624a4f07208
GET /v1/drugs/c3f91f92-c93c-42c5-9a5f-f624a4f07208?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h135037_smpc.pdf",
  "strength": null,
  "atc_label": "Tofacitinib",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg135037",
  "excipients": [
    "BRILJANTBLAUW FCF ALUMINIUMLAK (E133)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GLYCEROLTRIACETAAT (E 1518)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "INDIGOKARMIJN ALUMINIUMLAK (E 132)",
    "LACTOSE 0-WATER",
    "LACTOSE 1-WATER",
    "MACROGOL 4000",
    "MAGNESIUMSTEARAAT (E 470b)",
    "SILICIUMDIOXIDE (E 551)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "TOFACITINIBCITRAAT"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h135037.pdf",
  "authorised_at": "2026/07/29",
  "procedure_number": "IS/H/0698/002",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "135037",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about tofacitinib.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console